Replies to post #690063 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Really? Did I read something wrong?

[ATLnsider]

No mention, except that Northwest Biotherapeutics (NWBio) licensed the DC Vaccine (ATL-DC / aka DCVax) technology from UCLA decades ago.

As a result, NWBio is the only company / organization / entity in the world, that has the global rights to commercialize DCVax as a treatment for all or most solid tumor cancer patients around the world.

These global rights are protected by 100’s of global patents, and protect DCVax as a monotherapy and in combination with other approved treatments, including: PD-1 inhibitors, PDL-1 inhibitors, CSF-1R inhibitors, etc.:

[dstock07734]

Copying and pasting is great. It means I don't put BS on this board. It means what I post is authentic. Get it?

Have I reminded you since last year what you were trying to do would doom? I provided you series of genuine DDs to convince you to bail. But you would not listen. Fraudstein must have brainwashed you very bad. Keep in mind my Boma is yours now.

[SkyLimit2022]

iclight,

Thanks for asking. This factual point is definitely worth reviewing again ✅️

The peer-reviewed journal publication does name the company in the disclosures section (excerpted below).

Additionally, DCVax is a notion that appears on several of the graphs included in the body of the article.





https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-dr-linda-liau-has-joined-the-companys-scientific-advisory-board-301924864.html

https://www.nature.com/articles/s41467-024-48073-y
https://www.uclahealth.org/news/release/adding-immune-boosting-agent-personalized-cancer-vaccine